Flexibility and Control - A World of New Possibilities
PanTHERA CryoSolutions provides cryoprotectant products for use in a variety of cell and tissue systems. Our patented ice recrystallization inhibitors (IRIs) significantly improve post-thaw recovery and the quality of cell-based therapeutics.
Exceptional Protection
Our products provide exceptional protection against transient warming during both normal storage and distribution. Our IRIs offer beneficial options for alternative shipping methods that allow more flexibility in the supply chain of cryopreserved cells.
Benefits
Significant Cost Reductions
PanTHERA reduces operational including logistics and shipping. In certain applications IRIs allow for higher sub-zero storage of samples reducing the cost of banking cell inventories.
Improved Performance & Opportunities
PanTHERAs IRI’s improve post-thaw recovery and functionality of cells which can positively impact research and patient outcomes.
Applications
- Research and development
- Gene and cell therapy products
- Organ, tissue, and blood banking
- Biomanufacturing industry (such as viral vectors, oncolytic virus, recombinant proteins, vaccines)
- Assisted reproductive technologies
- Animal and aquaculture-specific breeding and preservation
News & Events
Revolutionizing Agriculture: The Crucial Role of Cryopreservation
The Vital Role of Ice Recrystallization Inhibitors in Cold Chain Management
Ice Recrystallization Inhibitors: A Promising Breakthrough in Cryopreservation
PanTHERA CryoSolutions Press Coverage
GlycoNet and PanTHERA CryoSolutions’ Journey: From Bench to Bedside
PanTHERA CryoSolutions Awarded Grant from Alberta Innovates in support of Groundbreaking Research in Cryopreservation Technology
What is transient warming and how does it affect cryopreservation?
PanTHERA CryoSolutions receives funding to support research and development project
How are Cryoprotective Agents (CPAs) used in cryopreservation?
What does thawing look like in cryopreservation?
